Amazon China President Dr Doug Gurr announced as next Chairman of the British Heart Foundation

2 March 2015        

doug gurr

Dr Doug Gurr has been announced as the next Chairman of the British Heart Foundation (BHF). He will succeed Philip Yea who will be stepping down as a trustee at the end of September 2015 after seven years.

Dr Gurr will take up the voluntary role on 1 October alongside his current positions as President of Amazon China and a Trustee of the Landmark Trust. 

Dr Gurr was Chairman of the Science Museum Group from 2010 to 2014, and before joining Amazon, was executive development director at Asda.

Dr Gurr said: “I’m delighted to have this opportunity to support the essential and amazing work of the BHF and build on the outstanding job of the current Chairman Philip Yea.

“I’m looking forward enormously to working with this wonderful and dedicated community of researchers, volunteers and supporters, professional staff and, of course, those affected by the devastating impact of heart disease.”

Philip Yea, our current Chairman, said: “Doug has vast experience in both the commercial and third sector, and has a proven track record in chairing a high profile institution. Everyone at the BHF looks forward to working with him to help achieve our vision of a world in which people don’t suffer from or die prematurely from cardiovascular disease.”

Mr Yea became a Trustee at the BHF in 2008 and was appointed chairman the following year. He is stepping down after serving the maximum terms as a Trustee.

Our world leading research

We are the UK’s leading heart charity and the largest independent funder of cardiovascular research. A quarter of all deaths in the UK are caused by cardiovascular disease and there are an estimated seven million people living with the condition.

For over 50 years we have invested in world leading research that has helped transform the lives of people living with heart and circulatory conditions. 

There are around 175,000 heart attacks in the UK each year, meaning someone suffers a heart attack every three minutes, but successful research has led to treatments that mean seven in ten people now survive.